QUOTE AND NEWS
Benzinga  May 13  Comment 
Pointer Telocation Ltd. (NASDAQ: PNTR) soared 59.38% to $4.59 after the company released its first quarter earnings results. Theragenics Corp. (NYSE: TGX) moved up 34.23% to $2.00 after the company announced receiving proposal of acquisition...
StreetInsider.com  May 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Medicinova%2C+Inc.+%28MNOV%29+Posts+Q1+Loss+of+14cShare/8319580.html for the full story.
Benzinga  Feb 27  Comment 
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: MediciNova Shares of MediciNova (NASDAQ: MNOV), the San Diego, CA biopharmaceutical company, rose 39% Tuesday on 175 times average...
StreetInsider.com  Feb 26  Comment 
CommonWealth REIT (NYSE: CWH) 29% HIGHER; Activist investors Corvex Management, LP and Related Fund Management team up, disclose 9.8% stake, request cease a value destroying equity offering and debt repurchase, and said stock worth up to...
Benzinga  Feb 25  Comment 
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq: MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced that it has received Fast Track...
Benzinga  Jan 4  Comment 
MediciNova (NASDAQ: MNOV) provides a development update on its two lead programs, MN-221 and MN-166. End-of-phase 2 guidance from the FDA and the newly extended patent protection (to expire no earlier than 2030) for use of MN-221 in the...
Benzinga  Dec 10  Comment 
MediciNova (NASDAQ: MNOV) announced that it has been granted a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, which covers the use of MN-221 for the treatment of acute exacerbations of...
Benzinga  Nov 21  Comment 
MediciNova Nasdaq: MNOV) announced the initiation of enrollment of a Phase 2a clinical trial with MN-166 (ibudilast) in prescription opioid or heroin abusers. The trial will be conducted at Columbia University and the New York State Psychiatric...
StreetInsider.com  Nov 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/MediciNova+%28MNOV%29+Receives+NoA+for+Two+MN-166+Patent+Apps+in+Europe/7889959.html for the full story.
StreetInsider.com  Nov 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Medicinova+%28MNOV%29+Files+%24100M+Mixed+Shelf/7889952.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki